Ironman International Ltd
XTSX:IMI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ironman International Ltd
XTSX:IMI
|
CA |
|
I
|
Innocan Pharma Corp
DUS:IP4
|
IL |
|
Kulicke and Soffa Industries Inc
NASDAQ:KLIC
|
SG |
|
M
|
MSP Recovery Inc
NASDAQ:MSPR
|
US |
|
E
|
Exelixis Inc
XMUN:EX9
|
US |
|
A
|
Amada Co Ltd
F:AA2
|
JP |
|
U
|
Unite Group PLC
XMUN:U1B
|
UK |
|
P
|
Ponce Financial Group Inc
F:73V0
|
US |
|
Kosmos Energy Ltd
NYSE:KOS
|
US |
|
Brightstar Resources Ltd
OTC:BTRAF
|
AU |
|
B
|
Bank of Georgia Group PLC
XBER:GEB
|
UK |
|
Noevir Holdings Co Ltd
TSE:4928
|
JP |
|
Europcar Mobility Group SA
F:E7CD
|
FR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IMI's stock price target?
Not Available
IMI does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Ironman International Ltd?
Projected CAGR
-7%
Over the last 10 years, the compound annual growth rate for Revenue has been 36%. The projected CAGR for the next 7 years is -7%.